13 AI News Investors Should Not Miss

Page 5 of 12

8. Tevogen Bio Holdings Inc. (NASDAQ:TVGN)

Number of Hedge Fund Holders: 10

Tevogen Bio Holdings Inc. (NASDAQ:TVGN) is a clinical-stage company specializing in immunotherapy, creating targeted T-cell treatments to meet unaddressed medical needs. The company owns a portfolio of patents and applications related to AI, developed without relying on third-party licenses.

Tevogen Bio (NASDAQ:TVGN) announced it will host an AI-focused panel at the 43rd Annual J.P. Morgan Healthcare Conference in San Francisco. Titled “AI in Biopharma: Next Frontier of Medical Innovation,” the panel will feature experts from Tevogen.AI, Microsoft, and Rubix Health, discussing AI’s role in transforming biopharma. Topics will include advancements in drug discovery, faster development, improved patient access, and cost efficiency, with a focus on Tevogen’s AI-driven efforts to improve precision T-cell therapies.

Page 5 of 12